Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|February 27, 2018
Visualizing AMPK Drug Binding Sites Through Crystallization of Full-Length Phosphorylated α2β1γ1 HeterotrimerChristopher G Langendorf, Jonathan S Oakhill, Bruce E KempCell Chemical Biology|July 22, 2017
Fake Inhibitors: AMPK Activation Trumps InhibitionChristopher G Langendorf, John W Scott, Bruce E KempPlos One|April 16, 2011
An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetesBindu Jayakrishnan, David E Hoke, Christopher G Langendorf, et al.Plos One|August 24, 2010
Characterisation of peptide microarrays for studying antibody-antigen binding using surface plasmon resonance imageryClaude Nogues, Hervé Leh, Christopher G Langendorf, et al.The Biochemical Journal|September 2, 2020
Protein kinase A negatively regulates VEGF-induced AMPK activation by phosphorylating CaMKK2 at serine 495Katrin Spengler, Darya Zibrova, Angela Woods, et al.International Journal of Molecular Sciences|January 30, 2021
Post-Translational Modifications of the Energy Guardian AMP-Activated Protein KinaseAshley J Ovens, John W Scott, Christopher G Langendorf, et al.Biochemical and Biophysical Research Communications|December 17, 2013
ATP sensitive bi-quinoline activator of the AMP-activated protein kinaseJohn W Scott, Jonathan S Oakhill, Naomi X Y Ling, et al.Bipolar Disorders|March 28, 2020
Functional analysis of an R311C variant of Ca2+ -calmodulin-dependent protein kinase kinase-2 (CaMKK2) found as a de novo mutation in a patient with bipolar disorderNaomi Xy Ling, Christopher G Langendorf, Ashfaqul Hoque, et al.Pharmacology & Therapeutics|June 1, 2020
New perspectives on the role of Drp1 isoforms in regulating mitochondrial pathophysiologyAyeshah A Rosdah, William J Smiles, Jonathan S Oakhill, et al.Pageof 4